Cluster randomised trial comparing one versus two doses of ivermectin for mass drug administration to control scabies

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1127297

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Scabies is a common skin disease in developing countries, in particular in the Pacific region. In the Western Province of Solomon Islands, one in two children suffer from the infestation, and 20% of the population. We know that mass drug administration with two doses of oral ivermectin is effective to reduce the burden of scabies in the community. We now propose a study to determine whether one single dose is as effective. This would have major public health benefits.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $540,512.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pacific Peoples Health

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

bacterial infection | epidemiology | impetigo | parasitic infection | scabies

Related Links